A Phase 3, Randomized, Placebo‐Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major Surgery

An intravenous (IV) formulation of meloxicam is being studied for moderate to severe pain management. This phase 3, randomized, multicenter, double‐blind, placebo‐controlled trial evaluated the safety of once‐daily meloxicam IV 30 mg in subjects following major elective surgery. Eligible subjects we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergese, Sergio D., Melson, Timothy I., Candiotti, Keith A., Ayad, Sabry S., Mack, Randall J., McCallum, Stewart W., Du, Wei, Gomez, Alexis, Marcet, Jorge E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899482/
https://www.ncbi.nlm.nih.gov/pubmed/30786162
http://dx.doi.org/10.1002/cpdd.666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899482/
https://www.ncbi.nlm.nih.gov/pubmed/30786162
http://dx.doi.org/10.1002/cpdd.666

Ejemplares similares